3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 29, 2008
Grant Date -
Dec 30, 2004
app pub date -
Jul 23, 2004
filing date -
Jul 21, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed are certain 3-(heteroaryl)alanine derivatives which bind VLA-4 and inhibit leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully